These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 26493351)
1. Association of the variants and haplotypes in the DOCK7, PCSK9 and GALNT2 genes and the risk of hyperlipidaemia. Guo T; Yin RX; Lin WX; Wang W; Huang F; Pan SL J Cell Mol Med; 2016 Feb; 20(2):243-65. PubMed ID: 26493351 [TBL] [Abstract][Full Text] [Related]
2. Association between the DOCK7, PCSK9 and GALNT2 Gene Polymorphisms and Serum Lipid levels. Guo T; Yin RX; Huang F; Yao LM; Lin WX; Pan SL Sci Rep; 2016 Jan; 6():19079. PubMed ID: 26744084 [TBL] [Abstract][Full Text] [Related]
3. Association of the variants in the BUD13-ZNF259 genes and the risk of hyperlipidaemia. Aung LH; Yin RX; Wu DF; Wang W; Liu CW; Pan SL J Cell Mol Med; 2014 Jul; 18(7):1417-28. PubMed ID: 24780069 [TBL] [Abstract][Full Text] [Related]
4. SYNE1-QK1 SNPs, G × G and G × E interactions on the risk of hyperlipidaemia. Zheng PF; Yin RX; Liu CX; Deng GX; Guan YZ; Wei BL J Cell Mol Med; 2020 May; 24(10):5772-5785. PubMed ID: 32281752 [TBL] [Abstract][Full Text] [Related]
5. Integrative mutation, haplotype and G × G interaction evidence connects ABGL4, LRP8 and PCSK9 genes to cardiometabolic risk. Guo T; Yin RX; Yao LM; Huang F; Pan L; Lin WX; Yang DZ; Pan SL Sci Rep; 2016 Nov; 6():37375. PubMed ID: 27853278 [TBL] [Abstract][Full Text] [Related]
6. DOCK7-ANGPTL3 SNPs and their haplotypes with serum lipid levels and the risk of coronary artery disease and ischemic stroke. Li WJ; Yin RX; Cao XL; Chen WX; Huang F; Wu JZ Lipids Health Dis; 2018 Feb; 17(1):30. PubMed ID: 29454388 [TBL] [Abstract][Full Text] [Related]
7. Associations of PRKN-PACRG SNPs and G × G and G × E interactions with the risk of hyperlipidaemia. Zheng PF; Yin RX; Wei BL; Liu CX; Deng GX; Guan YZ Sci Rep; 2020 Aug; 10(1):13010. PubMed ID: 32747620 [TBL] [Abstract][Full Text] [Related]
8. Characterization of LDLR rs5925 and PCSK9 rs505151 genetic variants frequencies in healthy subjects from northern Chile: Influence on plasma lipid levels. Rojas C; Ramírez H; Salazar LA; Kalergis AM; Gálvez AS; Escobar-Vera J J Clin Lab Anal; 2019 Nov; 33(9):e23001. PubMed ID: 31441123 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of PCSK9 levels and its genetic polymorphisms in women with polycystic ovary syndrome. Xavier LB; Sóter MO; Sales MF; Oliveira DK; Reis HJ; Candido AL; Reis FM; Silva IO; Gomes KB; Ferreira CN Gene; 2018 Feb; 644():129-136. PubMed ID: 29109005 [TBL] [Abstract][Full Text] [Related]
10. Association study of Devi K; Bhargave A; Ahmad I; Yadav A; Gupta R Ann Hum Biol; 2023 Feb; 50(1):56-62. PubMed ID: 36695028 [TBL] [Abstract][Full Text] [Related]
11. Multiple Hepatic Regulatory Variants at the GALNT2 GWAS Locus Associated with High-Density Lipoprotein Cholesterol. Roman TS; Marvelle AF; Fogarty MP; Vadlamudi S; Gonzalez AJ; Buchkovich ML; Huyghe JR; Fuchsberger C; Jackson AU; Wu Y; Civelek M; Lusis AJ; Gaulton KJ; Sethupathy P; Kangas AJ; Soininen P; Ala-Korpela M; Kuusisto J; Collins FS; Laakso M; Boehnke M; Mohlke KL Am J Hum Genet; 2015 Dec; 97(6):801-15. PubMed ID: 26637976 [TBL] [Abstract][Full Text] [Related]
12. The SRGAP2 SNPs, their haplotypes and G × E interactions on serum lipid traits. Miao L; Yin RX; Wu JZ; Yang S; Lin WX; Pan SL Sci Rep; 2017 Sep; 7(1):11626. PubMed ID: 28912560 [TBL] [Abstract][Full Text] [Related]
13. Genetic Regulation of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Plasma Levels and Its Impact on Atherosclerotic Vascular Disease Phenotypes. Pott J; Schlegel V; Teren A; Horn K; Kirsten H; Bluecher C; Kratzsch J; Loeffler M; Thiery J; Burkhardt R; Scholz M Circ Genom Precis Med; 2018 May; 11(5):e001992. PubMed ID: 29748315 [TBL] [Abstract][Full Text] [Related]
14. The CXCL12 SNPs and their haplotypes are associated with serum lipid traits. Qiu L; Yin RX; Nie RJ; Hu XJ; Khounphinith E; Zhang FH Sci Rep; 2019 Dec; 9(1):19524. PubMed ID: 31862910 [TBL] [Abstract][Full Text] [Related]
15. Association of the Deng GX; Yin RX; Guan YZ; Liu CX; Zheng PF; Wei BL; Wu JZ; Miao L Aging (Albany NY); 2020 Jun; 12(12):11893-11913. PubMed ID: 32568739 [TBL] [Abstract][Full Text] [Related]
16. Variations of the proprotein convertase subtilisin/kexin type 9 gene in coronary artery disease. Chiang SM; Yang YS; Yang SF; Tsai CF; Ueng KC J Int Med Res; 2020 Jan; 48(1):300060519839519. PubMed ID: 30947598 [TBL] [Abstract][Full Text] [Related]
17. DNA polymorphisms and haplotypes of apolipoprotein A5's attribution to the plasma triglyceride levels in Koreans. Choi JR; Nam CM; Kang DR; Eom SM; Lee HJ; Park CM; Im JW; Jang Y Yonsei Med J; 2007 Aug; 48(4):609-18. PubMed ID: 17722232 [TBL] [Abstract][Full Text] [Related]
18. Of PCSK9, cholesterol homeostasis and parasitic infections: possible survival benefits of loss-of-function PCSK9 genetic polymorphisms. Mbikay M; Mayne J; Seidah NG; Chrétien M Med Hypotheses; 2007; 69(5):1010-7. PubMed ID: 17502126 [TBL] [Abstract][Full Text] [Related]
19. Influence of PCSK9 polymorphisms on plasma lipids and response to atorvastatin treatment in Brazilian subjects. Anderson JM; Cerda A; Hirata MH; Rodrigues AC; Dorea EL; Bernik MM; Bertolami MC; Faludi AA; Hirata RD J Clin Lipidol; 2014; 8(3):256-64. PubMed ID: 24793346 [TBL] [Abstract][Full Text] [Related]
20. PCSK9 rs7552841 is associated with plasma lipids profiles in female Chinese adolescents without posttraumatic stress disorder. Guo Q; Si Y; Su M; Fan M; Lin J; Memon NH; Fang D Biosci Trends; 2017 Nov; 11(5):542-549. PubMed ID: 29081489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]